Chevron
Go back
Galapagos logo

Galapagos

Since December 31, 1998
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Icon, Mechelen-bovelingen, Belgium
Mechelen-bovelingen, Belgium
Icon, 251 — 500 employees
251 — 500 employees
Icon, Raised $5.42B
Raised $5.42B
Biopharma
Biotechnology
Clinical Trials
Health Care
Medical
Post-IPO Equity
July 14, 2019
$5.1B
See all investors and rounds